Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 09 2025
0mins
Source: Globenewswire
FDA-Approved Treatment for Rosacea: Journey Medical Corporation's Emrosi™, an FDA-approved treatment for inflammatory lesions of rosacea, was featured on the national TV segment "The Balancing Act," highlighting its unique formulation and benefits for patients.
Impact of Rosacea: Rosacea affects over 16 million Americans, significantly impacting their self-esteem and social interactions, with many patients reporting adverse effects on their professional lives due to the condition.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
